Table 2.
Macrophage colony stimulating factor (MCSF), interleukin-6 (IL-6), and tumour necrosis factor α (TNFα) concentrations on admission, at discharge, and six weeks later in patients with or without cardiac events during the two year follow up
| Cardiac event (n = 39) | No cardiac event (n = 72) | p Value | |
| On admission | |||
| MCSF (pg/ml) | 461 (309 to 603) | 372 (281 to 601) | 0.15 |
| IL-6 (pg/ml) | 7.1 (4.4 to 11.8) | 4.8 (2.8 to 10.7) | 0.12 |
| TNFα (pg/ml) | 4.7 (3.5 to 5.8) | 3.7 (2.8 to 5.1) | 0.10 |
| At discharge | |||
| MCSF (pg/ml) | 521 (358 to 703) | 417 (303 to 574) | 0.06 |
| IL-6 (pg/ml) | 6 (3.0 to 9.6) | 4.7 (2.95 to 10.25) | 0.80 |
| TNFα (pg/ml) | 5.1 (3.6 to 7.0) | 4.6 (3.3 to 6.3) | 0.23 |
| At six weeks | |||
| MCSF (pg/ml) | 424 (315 to 578) | 306 (233 to 396) | 0.0008 |
| IL-6 (pg/ml) | 6.6 (3.5 to 11.2) | 4.5 (2.3 to 7.4) | 0.01 |
| TNFα (pg/ml) | 4.6 (3.3 to 6.1) | 4.3 (3.2 to 5.7) | 0.38 |
Values are median (25th to 75th centile).